250 related articles for article (PubMed ID: 21550827)
1. Non-bladder cancer mortality in patients with urothelial cancer of the bladder.
Scosyrev E; Wu G; Golijanin D; Messing E
Urol Oncol; 2013 Jul; 31(5):656-63. PubMed ID: 21550827
[TBL] [Abstract][Full Text] [Related]
2. Grade and stage at presentation do not predict mortality in patients with bladder cancer who survive their disease.
Messing EM; Madeb R; Feng C; Stephenson L; Gilchrist KW; Young T; Gee J
J Clin Oncol; 2009 May; 27(15):2443-9. PubMed ID: 19332735
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
4. Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: a SEER database analysis.
Canter D; Egleston B; Wong YN; Smaldone MC; Simhan J; Greenberg RE; Uzzo RG; Kutikov A
Urol Oncol; 2013 Aug; 31(6):866-70. PubMed ID: 21906968
[TBL] [Abstract][Full Text] [Related]
5. The burden of bladder cancer in men and women: analysis of the years of life lost.
Scosyrev E; Golijanin D; Wu G; Messing E
BJU Int; 2012 Jan; 109(1):57-62. PubMed ID: 21883817
[TBL] [Abstract][Full Text] [Related]
6. The impact of marriage on bladder cancer mortality.
Nelles JL; Joseph SA; Konety BR
Urol Oncol; 2009; 27(3):263-7. PubMed ID: 18625568
[TBL] [Abstract][Full Text] [Related]
7. Microscopic invasion of perivesical fat by urothelial carcinoma: implications for prognosis and pathology practice.
Scosyrev E; Yao J; Messing E
Urology; 2010 Oct; 76(4):908-13; discussion 914. PubMed ID: 20709375
[TBL] [Abstract][Full Text] [Related]
8. Nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysis.
Sun M; Bianchi M; Hansen J; Abdollah F; Trinh QD; Lughezzani G; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
Int J Urol; 2013 Apr; 20(4):372-80. PubMed ID: 23039208
[TBL] [Abstract][Full Text] [Related]
9. Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment?
Scosyrev E; Yao J; Messing E
Urology; 2009 Apr; 73(4):822-7. PubMed ID: 19193403
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program.
Konety BR; Joslyn SA
J Urol; 2003 Nov; 170(5):1765-71. PubMed ID: 14532772
[TBL] [Abstract][Full Text] [Related]
12. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
13. Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy.
Simone G; Papalia R; Ferriero M; Guaglianone S; Castelli E; Collura D; Muto G; Gallucci M
Int J Urol; 2013 Apr; 20(4):390-7. PubMed ID: 22970939
[TBL] [Abstract][Full Text] [Related]
14. Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis.
Abdollah F; Gandaglia G; Thuret R; Schmitges J; Tian Z; Jeldres C; Passoni NM; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI; Sun M
Cancer Epidemiol; 2013 Jun; 37(3):219-25. PubMed ID: 23485480
[TBL] [Abstract][Full Text] [Related]
15. Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.
Fairey AS; Jacobsen NE; Chetner MP; Mador DR; Metcalfe JB; Moore RB; Rourke KF; Todd GT; Venner PM; Voaklander DC; Estey EP
J Urol; 2009 Jul; 182(1):85-92; discussion 93. PubMed ID: 19447413
[TBL] [Abstract][Full Text] [Related]
16. Use of restaging bladder tumor resection for bladder cancer among Medicare beneficiaries.
Skolarus TA; Ye Z; Montgomery JS; Weizer AZ; Hafez KS; Lee CT; Miller DC; Wood DP; Montie JE; Hollenbeck BK
Urology; 2011 Dec; 78(6):1345-9. PubMed ID: 21996111
[TBL] [Abstract][Full Text] [Related]
17. Marital status independently predicts testis cancer survival--an analysis of the SEER database.
Abern MR; Dude AM; Coogan CL
Urol Oncol; 2012; 30(4):487-93. PubMed ID: 20870430
[TBL] [Abstract][Full Text] [Related]
18. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
[TBL] [Abstract][Full Text] [Related]
19. Marital status and survival following bladder cancer.
Datta GD; Neville BA; Kawachi I; Datta NS; Earle CC
J Epidemiol Community Health; 2009 Oct; 63(10):807-13. PubMed ID: 19468015
[TBL] [Abstract][Full Text] [Related]
20. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.
Lughezzani G; Sun M; Perrotte P; Shariat SF; Jeldres C; Budäus L; Latour M; Widmer H; Duclos A; Bénard F; McCormack M; Montorsi F; Karakiewicz PI
Urology; 2010 Feb; 75(2):321-7. PubMed ID: 19962727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
